FREE + EASY cancellation anytime for any reason
• Targets both GHRH and ghrelin receptor pathways
• Supports the body's natural, pulsatile growth hormone release
• Designed to minimize impact on cortisol and appetite hormones
• May help support recovery and lean body composition pathways
• Delivered as a clinician-supervised, foundational peptide combination
CJC-1295 and Ipamorelin are two complementary peptides that work through distinct receptor pathways to support the body's natural growth hormone release. CJC-1295 is a growth hormone-releasing hormone (GHRH) analog that binds to GHRH receptors on the pituitary gland, while Ipamorelin is a selective ghrelin receptor agonist that stimulates GH release through a separate pathway without significantly affecting cortisol or appetite hormones. Used together, these peptides are designed to produce a synergistic, pulsatile increase in the body's own growth hormone secretion, mimicking the body's natural release patterns rather than introducing exogenous GH directly. EdgeRx offers this combination as a foundational clinician-supervised peptide protocol, prescribed by licensed physicians for eligible patients pursuing recovery, body composition, or performance-related goals.
No clinic visits. No phone tag. No waiting rooms.
Tell us about your goals, health history, and lifestyle. Licensed providers in all 50 states.
Your medication is made at a licensed pharmacy and shipped in plain packaging.
100% online visits and prescriptions. Made at licensed USA pharmacies. GLP-1, peptide, and hormone plans — prescribed by a doctor.
Shipping fees apply. All medications require a prescription from a licensed provider. Compounded medications are not FDA-approved.
